Volume 13, Issue 1 (2025)
Health Educ Health Promot 2025, 13(1): 1001-1010 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mashudi M, Masyitah D, Fahmi I, Dahrizal D, Idramsyah I. Impact of the TB SEHAT Application on Medication Adherence in Pulmonary Tuberculosis Patients at Putri Ayu Health Center, Jambi City. Health Educ Health Promot 2025; 13 (1) :1001-1010
URL: http://hehp.modares.ac.ir/article-5-77780-en.html
URL: http://hehp.modares.ac.ir/article-5-77780-en.html
1- Department of Nursing, Health Polytechnic of Jambi, Indonesia , mashudi.poltekkesjambi@gmail.com
2- Department of Nursing, Health Polytechnic of Jambi, Indonesia
3- Department of Nursing, Health Polytechnic of Bengkulu, Indonesia
2- Department of Nursing, Health Polytechnic of Jambi, Indonesia
3- Department of Nursing, Health Polytechnic of Bengkulu, Indonesia
Abstract: (45 Views)
Aims. This study aimed to evaluate the impact of the TB SEHAT Application on medication adherence among pulmonary TB patients in Jambi City.
Materials & Methods. This quasi-experimental study employed a one group pretest-posttest with control design, comprising two groups: an intervention group, which received TB SEHAT app-based education and a medication reminder program, and a control group, which received standard care from medication supervisors. Each group included 37 participants, selected through simple random sampling. Data collection took place from May 13 to August 30, 2024, within the Putri Ayu Health Center service area. Data analysis was performed using an ANCOVA test.
Findings. The mean age of respondents in the intervention group was 43.76 years, with a standard deviation of 16.31 years. Following the use of the TB SEHAT application, the mean adherence to anti-tuberculosis medication (OAT) was 127.30 on the TB Medication Adherence Scale (TBMAS), with a standard deviation of 5.22. In contrast, the mean adherence in the group receiving standard treatment supervision was 121.41, with a standard deviation of 6.43. An independent t-test yielded a p-value of 0.001, indicating a significant difference in adherence between the TB SEHAT application group and the standard treatment group.
Conclusion. The TB SEHAT application effectively improves adherence to OAT in patients with pulmonary tuberculosis.
Materials & Methods. This quasi-experimental study employed a one group pretest-posttest with control design, comprising two groups: an intervention group, which received TB SEHAT app-based education and a medication reminder program, and a control group, which received standard care from medication supervisors. Each group included 37 participants, selected through simple random sampling. Data collection took place from May 13 to August 30, 2024, within the Putri Ayu Health Center service area. Data analysis was performed using an ANCOVA test.
Findings. The mean age of respondents in the intervention group was 43.76 years, with a standard deviation of 16.31 years. Following the use of the TB SEHAT application, the mean adherence to anti-tuberculosis medication (OAT) was 127.30 on the TB Medication Adherence Scale (TBMAS), with a standard deviation of 5.22. In contrast, the mean adherence in the group receiving standard treatment supervision was 121.41, with a standard deviation of 6.43. An independent t-test yielded a p-value of 0.001, indicating a significant difference in adherence between the TB SEHAT application group and the standard treatment group.
Conclusion. The TB SEHAT application effectively improves adherence to OAT in patients with pulmonary tuberculosis.
Article Type: Original Research |
Subject:
Technology of Health Education
Received: 2024/11/1 | Accepted: 2024/12/16 | Published: 2025/01/21
Received: 2024/11/1 | Accepted: 2024/12/16 | Published: 2025/01/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |